Immune responses against SARS-CoV-2 variants after two and three doses of vaccine in B-cell malignancies: UK PROSECO studySean H. Lim, David Goldblatt, Nicola Campbell et al.|Nature Cancer|2022Cited by 91
Ethnicity, length of time on the register and sex predict donor availability at the confirmatory typing stageRobert Lown, Bronwen E. Shaw, Steven G. E. Marsh et al.|Bone Marrow Transplantation|2014Cited by 41
Myeloproliferative Neoplasm Quality of Life (MPN-QOL) Study Group: MPN Experimental Assessment of Symptoms By Utilizing Repetitive Evaluation (MEASURE) TrialAllison Gathany, Ruben A. Mesa, Robyn M. Scherber et al.|Blood|2018Cited by 1
Myeloproliferative Neoplasm Quality of Life (MPN-QOL) Study Group: Interim Results from the MPN Experimental Assessment of Symptoms By Utilizing Repetitive Evaluation (MEASURE) TrialAllison H. Scotch, Ruben A. Mesa, Robyn M. Scherber et al.|Blood|2016Cited by 0